Why the study?
To provide an overview of the interaction between endothelial inflammatory response and pulmonary hypertension, and how regulating this response can improve patient quality of life.
The inflammatory response mediated by endothelial cells plays a significant role in the development and progression of pulmonary hypertension, highlighting a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Endothelial inflammation is a druggable target in PH; extends mechanistic evidence to prioritize anti-inflammatory trials.
PURPOSE OF REVIEW: To provide an overview of the interaction between endothelial inflammatory response and pulmonary hypertension (PH), and how the associated inflammatory response can be regulated to improve the life quality of patients with PH. A systematic review was performed to focus on the recent research about the subject. RECENT FINDINGS: Accumulated evidence suggests that the inflammatory response of endothelial cells (ECs) plays an important role in the occurrence and progression of various types of PH. The inflammatory response of ECs leads to ECs hyper-proliferation, anti-apoptosis, endothelial barrier function damage and vasoconstriction through activating multiple pathways and secreting the mediators, and finally accelerating pulmonary vascular remodeling and the progression of PH. SUMMARY: The inflammatory response mediated by ECs plays a significant role in the development of PH. A better exploration of the role of endothelial inflammatory response in PH will be conducive to effectively prevent and treat PH.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: